RK Swamy BBDO wins Rs 12-cr Revital portfolio
RK Swamy BBDO Delhi has bagged the Revital portfolio comprising Revital, Revitalite (protein supplement), Revital new variants, Chericof Cough Syrup, Chericold N Flu (cold tablets), Pepfiz Antacid, Pepflux Antacid, and Chyawan Active (Chyawanprash). These brands were earlier handled by Grey Worldwide. According to industry estimates, the account size is pegged at Rs 12 crore.
RK Swamy BBDO Delhi has bagged the Revital portfolio comprising Revital, Revitalite (protein supplement), Revital new variants, Chericof Cough Syrup, Chericold N Flu (cold tablets), Pepfiz Antacid, Pepflux Antacid, and Chyawan Active (Chyawanprash). These brands were earlier handled by Grey Worldwide. According to industry estimates, the account size is pegged at Rs 12 crore.
The agencies pitching for the account included incumbent Grey Worldwide, O&M, McCann Erickson, FCB Ulka, Saatchi & Saatchi, Mudra, and TBWA, besides RK Swamy BBDO.
On awarding the business to RK Swamy BBDO, Brijesh Kapil, Director – Global Consumer Healthcare, Ranbaxy, said, “The reason for appointing RK Swamy BBDO was its thorough understanding of the brief and providing 360-degree cost-effective solutions. The agency displayed excellent strategic thinking as well as creative execution. The agency used the research provided by us most effectively. The ideas given for digital media were also very good.”
Revital will approach a 360-degree communication towards its brand strategy using print, TV, OOH and below-the-line activities.
